CUROSURF Poractant Alfa Injection

DESCRIPTION

CUROSURF (poractant alfa)  is a surfactant intended only for intratracheal use ,indicated for the rescue treatment, including the reduction of mortality and pneumothoraces associated with  Respiratory Distress Syndrome (RDS) in premature infants.

CUROSURF (poractant alfa) is a sterile, non-pyrogenic pulmonary surfactant. It is an extract of natural porcine lung surfactant consisting of 99% polar lipids (mainly phospholipids) and 1% hydrophobic low molecular weight proteins (surfactant associated proteins SP-B and SP-C).

CUROSURF is a white to creamy white suspension of poractant alfa. Each milliliter of suspension contains 80 mg of poractant alfa (surfactant extract) that includes 76 mg of phospholipids and 1 mg of protein of which 0.45 mg is SP-B and 0.59 mg is SP-C.

Manufacturer :  Abbott